期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Enhancement in Bioavailability of CurCousin®, A Minor Metabolite from Curcuma longa by Addition of BioPerine® —A Pharmacokinetic Study
1
作者 Muhammed Majeed Kalyanam Nagabhushanam +2 位作者 Sarang Bani Anjali Pandey Smitha Thazhathidath 《Journal of Biosciences and Medicines》 2024年第2期282-293,共12页
In recent years, metabolic syndrome has been a growing health concern across the world. The role of nutraceuticals and functional foods in this area has a significant place due to the adverse effects of contemporary m... In recent years, metabolic syndrome has been a growing health concern across the world. The role of nutraceuticals and functional foods in this area has a significant place due to the adverse effects of contemporary modes of treatment. CurCousin<sup>®</sup> is a nutritional ingredient containing bioactive Calebin A, (analog of Curcumin) with self-affirmed GRAS status. CurCousin<sup>®</sup> has been a clinically studied dietary supplement ingredient with a positive impact on body weight, lipid levels and metabolic health. Bioenhancers play an important role in increasing the bioavailability of the active in turn enhancing efficacy as well as reducing the dosage required to achieve the therapeutic effect. This study investigated the possible pharmacokinetic interaction between CurCousin<sup>®</sup> at two different doses (2.25 and 4.5 mg/kg) in the presence and absence of BioPerine<sup>®</sup> (0.27 mg/kg), a natural bioenhancer in Sprague-Dawley rats. The results revealed that the addition of BioPerine<sup>®</sup> into CurCousin<sup>®</sup> (2.25 mg/kg) half the dose when administered enhances the bioavailability and was equipotent to CurCousin<sup>®</sup> (4.5 mg/kg) double the dose without BioPerine<sup>®</sup>. Thus, leading to future clinical studies to evaluate its improved pharmacological efficacy as well as reduced therapeutic dosage. 展开更多
关键词 Metabolic Health BIOAVAILABILITY PHARMACOKINETICS CurCousin® BioPerine® calebin A
暂未订购
中药姜黄的两种提取物对肝癌细胞生长抑制的比较 被引量:4
2
作者 陈亮 李绍青 +2 位作者 刘常浩 郭航 李燕 《第四军医大学学报》 北大核心 2009年第1期7-10,共4页
目的:比较传统中药姜黄的两种提取物姜黄素(Curcumin)和Calebin-A对肝癌细胞(HepG2)的生长抑制作用.方法:应用MTT比色法检测姜黄素和Calebin-A对肝癌细胞体外生长的抑制作用;平板克隆检测两种提取物处理前后HepG2细胞的克隆形成能力;TU... 目的:比较传统中药姜黄的两种提取物姜黄素(Curcumin)和Calebin-A对肝癌细胞(HepG2)的生长抑制作用.方法:应用MTT比色法检测姜黄素和Calebin-A对肝癌细胞体外生长的抑制作用;平板克隆检测两种提取物处理前后HepG2细胞的克隆形成能力;TUNEL法测定两种药物诱导肝癌细胞凋亡的作用.结果:姜黄素和Calebin-A对肝癌细胞的生长均有抑制作用,且随药物作用的浓度升高和时间延长,抑制效果增强.同一浓度下Calebin-A对细胞生长的抑制作用大于姜黄素,姜黄素和Calebin-A作用肝癌细胞48h后,半数细胞抑制作用所需浓度(IC50)分别约为25μmol/L和10μmol/L.相同浓度时(25μmol/L)两种提取物均可使肝癌细胞的克隆形成能力明显下降,且Calebin-A对细胞克隆形成能力影响更大.25μmol/L姜黄素及Calebin-A作用肝癌细胞48h后,Calebin-A诱导细胞发生凋亡的比例明显大于姜黄素.结论:姜黄素和Calebin-A对肝癌细胞的生长均有抑制作用,而且Calebin-A这种新的植物姜黄提取物对细胞的抑制作用更强. 展开更多
关键词 姜黄 姜黄素 calebin—A 肝肿瘤 凋亡
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部